Modulation of Large-Scale Functional Networks Occurs in MS Patients Starting Fingolimod or Natalizumab: A 2-Year Resting State Functional Connectivity Study (S31.003) — Maria A. Rocca (2019) | RDL Network
Modulation of Large-Scale Functional Networks Occurs in MS Patients Starting Fingolimod or Natalizumab: A 2-Year Resting State Functional Connectivity Study (S31.003)
Article 2019 en
Authors
MR
Maria A. Rocca
CM
Carlotta Marchetti
PV
Paola Valsasina
Abstract
1 min read
To investigate longitudinal changes of resting state (RS) functional connectivity (FC) in relapsing-remitting (RR) multiple sclerosis (MS) patients treated with fingolimod (FTY) and natalizumab (NAT) over two years of treatment.
Discussion(0)
No comments yet. Be the first to comment.